Unknown

Dataset Information

0

Effects of ACEI/ARB in hypertensive patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled studies.


ABSTRACT: BACKGROUND: The effects of angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) on cardiovascular (CV) risk in hypertensive patients with type 2 diabetes mellitus (T2 DM) are uncertain. Our objective was to analyze the effects of ACE/ARBs, on the incidence of myocardial infarction, stroke, CV events, and all-cause mortality in hypertensive patients with T2 DM. METHOD: PubMed and Embase databases were searched through January 2014 to identify studies meeting a priori inclusion criteria and references in the published articles were also reviewed. Two investigators independently extracted the information with either fixed-effect model or random-effect model to assess the effects of ACE/ARBs treatment in hypertensive patients with T2 DM. RESULTS: Ten randomized controlled studies were included with a total of 21,871 participants. Overall, treatment with ACE/ARBs in hypertensive patients with T2 DM was associated with a statistically significant 10% reduction in CV events, pooled hazard ratio (HR) of 0.90 [95% confidence intervals (CI): 0.82-0.98] with no heterogeneity (I2 = 19.50%; P = 0.275);and 17% reduction in CV mortality, pooled HR of 0.83 [95% CI: 0.72-0.96] with no heterogeneity (I2 = 0.9%; P = 0.388). ACE/ARBs was not associated with MI, stroke and all-cause mortality. CONCLUSIONS: Treatment with ACE/ARBs results in significant reduction in CV events and mortality in hypertensive patients with T2 DM.

SUBMITTER: Hao G 

PROVIDER: S-EPMC4221690 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

altmetric image

Publications

Effects of ACEI/ARB in hypertensive patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled studies.

Hao Guang G   Wang Zengwu Z   Guo Rui R   Chen Zuo Z   Wang Xin X   Zhang Linfeng L   Li Wei W  

BMC cardiovascular disorders 20141025


<h4>Background</h4>The effects of angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) on cardiovascular (CV) risk in hypertensive patients with type 2 diabetes mellitus (T2 DM) are uncertain. Our objective was to analyze the effects of ACE/ARBs, on the incidence of myocardial infarction, stroke, CV events, and all-cause mortality in hypertensive patients with T2 DM.<h4>Method</h4>PubMed and Embase databases were searched through January 2014 to identify stu  ...[more]

Similar Datasets

| S-EPMC8799108 | biostudies-literature
| S-EPMC7747108 | biostudies-literature
| S-EPMC6544490 | biostudies-literature
| S-EPMC5447671 | biostudies-other
| S-EPMC6221554 | biostudies-literature
| S-EPMC8096582 | biostudies-literature
| S-EPMC6709066 | biostudies-other
| S-EPMC4705121 | biostudies-other
| S-EPMC7483641 | biostudies-literature
| S-EPMC8712820 | biostudies-literature